Lv21
146 积分 2024-11-08 加入
POS0900 SECUKINUMAB 150 MG PROVIDES SUSTAINED IMPROVEMENT IN SIGNS AND SYMPTOMS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM THE PREVENT STUDY
6小时前
已完结
EULAR 2025
14天前
已关闭
Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)
17天前
已完结
Novel therapies for refractory idiopathic inflammatory myopathy-associated interstitial lung disease
19天前
已完结
Rheumatoid Arthritis in Adults
21天前
已完结
The Efficacy of Oral Icotrokinra versus Injectable IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Comparative Meta-Analysis
1个月前
已完结
Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs
1个月前
已完结
Advances in the treatment of eosinophilic granulomatosis with polyangiitis
1个月前
已完结
Alopecia areata: Emerging therapies and up-to-date management strategies
1个月前
已完结
Pyoderma Gangrenosum Phenotype Classification
1个月前
已完结
皖公网安备34019202002308
